Cargando…
Impact of comprehensive molecular testing to reduce antibiotic use in community-acquired pneumonia (RADICAP): a randomised, controlled, phase IV clinical trial protocol
INTRODUCTION: Community-acquired pneumonia (CAP) continues to be a major health problem worldwide and is one of the main reasons for prescribing antibiotics. However, the causative agent is often not identified, resulting in antibiotic overtreatment, which is a key driver of antimicrobial resistance...
Autores principales: | Abelenda-Alonso, Gabriela, Rombauts, Alexander, Gudiol, Carlota, Meije, Yolanda, Clemente, Mercedes, Ortega, Lucía, Ardanuy, Carmen, Niubó, Jordi, Padullés, Ariadna, Videla, Sebastian, Tebe, Cristian, Carratalà, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443276/ https://www.ncbi.nlm.nih.gov/pubmed/32819999 http://dx.doi.org/10.1136/bmjopen-2020-038957 |
Ejemplares similares
-
Influenza and Bacterial Coinfection in Adults With Community-Acquired Pneumonia Admitted to Conventional Wards: Risk Factors, Clinical Features, and Outcomes
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020) -
Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial—a trial protocol
por: Rombauts, Alexander, et al.
Publicado: (2020) -
Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
por: Abelenda-Alonso, Gabriela, et al.
Publicado: (2020) -
Host- and Pathogen-Related Factors for Acute Cardiac Events in Pneumococcal Pneumonia
por: Rombauts, Alexander, et al.
Publicado: (2020) -
Whole-Blood Gene Expression Profiles Associated with Mortality in Community-Acquired Pneumonia
por: Viasus, Diego, et al.
Publicado: (2023)